Cellumed Co (049180.KQ) Stock Price

Cellumed Co Price

CLOSED
1,009.00KRW+0.00 (+0.00 %)
Market closed

Over the last 19 years Cellumed Co grew revenue by 13.1% annually, reaching 140.19 B KRW. For Cellumed Co, the net margin of -1.6% is down versus 8.2% a few years ago. The stock trades about 77% above its 52-week low.

Cellumed Co stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cellumed Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cellumed Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cellumed Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cellumed Co Stock Price History
DateCellumed Co Price
8/4/20261,009.00 KRW
8/3/20261,009.00 KRW
7/31/20261,009.00 KRW
7/30/20261,009.00 KRW
7/29/20261,009.00 KRW
7/28/20261,009.00 KRW
7/27/20261,009.00 KRW
7/24/20261,009.00 KRW
7/23/20261,009.00 KRW
7/22/20261,009.00 KRW
7/21/20261,009.00 KRW
7/20/20261,009.00 KRW
7/16/20261,009.00 KRW
7/15/20261,009.00 KRW
7/14/20261,009.00 KRW
7/13/20261,009.00 KRW
7/10/20261,009.00 KRW
7/9/20261,009.00 KRW
7/8/20261,009.00 KRW
7/7/20261,009.00 KRW
7/6/20261,009.00 KRW
7/3/20261,009.00 KRW
7/2/20261,009.00 KRW
7/1/20261,009.00 KRW
6/30/20261,009.00 KRW
6/29/20261,009.00 KRW
6/26/20261,009.00 KRW
6/25/20261,009.00 KRW
6/24/20261,009.00 KRW
6/23/20261,009.00 KRW
6/22/20261,009.00 KRW
6/19/20261,009.00 KRW
6/18/20261,009.00 KRW
6/17/20261,009.00 KRW
6/16/20261,009.00 KRW
6/15/20261,009.00 KRW
6/12/20261,009.00 KRW
6/11/20261,009.00 KRW
6/10/20261,009.00 KRW
6/9/20261,009.00 KRW
6/8/20261,009.00 KRW
6/5/20261,009.00 KRW
6/4/20261,009.00 KRW
6/2/20261,009.00 KRW
6/1/20261,009.00 KRW
5/29/20261,009.00 KRW
5/28/20261,009.00 KRW
5/27/20261,009.00 KRW
5/26/20261,009.00 KRW
5/22/20261,009.00 KRW
5/21/20261,009.00 KRW
5/20/20261,009.00 KRW
5/19/20261,009.00 KRW
5/18/20261,009.00 KRW
5/15/20261,009.00 KRW
5/14/20261,009.00 KRW
5/13/20261,009.00 KRW
5/12/20261,009.00 KRW
5/11/20261,009.00 KRW
5/8/20261,009.00 KRW
5/7/20261,009.00 KRW
5/6/20261,009.00 KRW
5/4/20261,009.00 KRW
4/30/20261,009.00 KRW
4/29/20261,009.00 KRW
4/28/20261,009.00 KRW
4/27/20261,009.00 KRW
4/24/20261,009.00 KRW
4/23/20261,009.00 KRW
4/22/20261,009.00 KRW
4/21/20261,009.00 KRW
4/20/20261,009.00 KRW
4/17/20261,009.00 KRW
4/16/20261,009.00 KRW
4/15/20261,009.00 KRW
4/14/20261,009.00 KRW
4/13/20261,009.00 KRW
4/10/20261,009.00 KRW
4/9/20261,009.00 KRW
4/8/20261,009.00 KRW
4/7/20261,009.00 KRW
4/6/20261,009.00 KRW
4/3/20261,009.00 KRW
4/2/20261,009.00 KRW
4/1/20261,009.00 KRW
3/31/20261,009.00 KRW
3/30/20261,009.00 KRW
3/27/20261,009.00 KRW
3/26/20261,009.00 KRW
3/25/20261,009.00 KRW
3/24/20261,009.00 KRW
3/23/20261,009.00 KRW
3/20/20261,009.00 KRW
3/19/20261,009.00 KRW
3/18/20261,009.00 KRW
3/17/20261,009.00 KRW
3/16/20261,009.00 KRW
3/13/20261,110.00 KRW
3/12/20261,245.00 KRW
3/11/20261,355.00 KRW
3/10/20261,043.00 KRW
3/9/20261,050.00 KRW
3/6/20261,150.00 KRW
3/5/20261,160.00 KRW
3/4/20261,033.00 KRW
3/3/20261,279.00 KRW
2/27/20261,422.00 KRW
2/26/20261,410.00 KRW
2/25/20261,468.00 KRW
2/24/20261,375.00 KRW
2/23/20261,371.00 KRW
2/20/20261,402.00 KRW
2/19/20261,507.00 KRW
2/13/20261,478.00 KRW
2/12/20261,590.00 KRW
2/11/20261,692.00 KRW
2/10/20261,755.00 KRW
2/9/20261,900.00 KRW
2/6/20261,503.00 KRW
2/5/20261,491.00 KRW
2/4/20261,600.00 KRW
2/3/20261,568.00 KRW
2/2/20261,500.00 KRW
1/30/20261,639.00 KRW
1/29/20261,773.00 KRW
1/28/20261,895.00 KRW
1/27/20262,010.00 KRW
1/26/20262,110.00 KRW
1/23/20262,570.00 KRW
1/22/20262,570.00 KRW
1/21/20262,505.00 KRW
1/20/20262,550.00 KRW
1/19/20262,360.00 KRW
1/16/20261,818.00 KRW
1/15/20261,482.00 KRW
1/14/20261,437.00 KRW
1/13/20261,535.00 KRW
1/12/20261,460.00 KRW
1/9/20261,475.00 KRW
1/8/20261,686.00 KRW
1/7/20261,427.00 KRW
1/6/20261,098.00 KRW
1/5/2026845.00 KRW
1/2/2026808.00 KRW
12/30/20251,154.00 KRW
12/29/20251,648.00 KRW
12/26/20251,896.00 KRW
12/24/20251,459.00 KRW
12/23/20251,123.00 KRW
12/22/2025864.00 KRW
12/19/2025665.00 KRW
12/18/2025690.00 KRW
12/17/2025702.00 KRW
12/16/2025719.00 KRW
12/15/2025731.00 KRW
12/12/2025750.00 KRW
12/11/2025769.00 KRW
12/10/2025757.00 KRW
12/9/2025757.00 KRW
12/8/2025760.00 KRW
12/5/2025784.00 KRW
12/4/2025792.00 KRW
12/3/2025788.00 KRW
12/2/2025788.00 KRW
12/1/2025759.00 KRW
11/28/2025788.00 KRW
11/27/2025701.00 KRW
11/26/2025708.00 KRW
11/25/2025688.00 KRW
11/24/2025685.00 KRW
11/21/2025705.00 KRW
11/20/2025701.00 KRW
11/19/2025700.00 KRW
11/18/2025763.00 KRW
11/17/2025750.00 KRW
11/14/2025790.00 KRW
11/13/2025858.00 KRW
11/12/2025660.00 KRW
11/11/2025666.00 KRW
11/10/2025673.00 KRW
11/7/2025665.00 KRW
11/6/2025679.00 KRW
11/5/2025700.00 KRW
11/4/2025711.00 KRW
11/3/2025700.00 KRW
10/31/2025689.00 KRW
10/30/2025671.00 KRW
10/29/2025686.00 KRW
10/28/2025686.00 KRW
10/27/2025674.00 KRW
10/24/2025702.00 KRW
10/23/2025710.00 KRW
10/22/2025744.00 KRW
10/21/2025746.00 KRW
10/20/2025780.00 KRW
10/17/2025761.00 KRW
10/16/2025805.00 KRW
10/15/2025784.00 KRW
10/14/2025731.00 KRW
10/13/2025749.00 KRW
10/10/2025711.00 KRW
10/2/2025687.00 KRW
10/1/2025682.00 KRW
9/30/2025703.00 KRW
9/29/2025699.00 KRW
9/26/2025687.00 KRW
9/25/2025709.00 KRW
9/24/2025711.00 KRW
9/23/2025719.00 KRW
9/22/2025741.00 KRW
9/18/2025729.00 KRW
9/17/2025770.00 KRW
9/16/2025775.00 KRW
9/15/2025746.00 KRW
9/12/2025775.00 KRW
9/11/2025812.00 KRW
9/10/2025780.00 KRW
9/9/2025802.00 KRW
9/8/2025617.00 KRW
9/5/2025607.00 KRW
9/4/2025603.00 KRW
9/3/2025585.00 KRW
9/2/2025613.00 KRW
9/1/2025627.00 KRW
8/29/2025667.00 KRW
8/28/2025628.00 KRW
8/27/2025580.00 KRW
8/26/2025570.00 KRW
8/25/2025572.00 KRW
8/22/2025570.00 KRW
8/21/2025601.00 KRW
8/20/2025578.00 KRW
8/19/2025605.00 KRW
8/18/2025612.00 KRW
8/14/2025873.00 KRW
8/13/2025880.00 KRW
8/12/2025879.00 KRW
8/11/2025882.00 KRW
8/8/2025885.00 KRW
8/7/2025892.00 KRW
Access this data via the Eulerpool API
Get Free API Key

Cellumed Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
10.84 B KRW
-12.45 B KRW
-9.27 B KRW
Jan 1, 2019
17.92 B KRW
-36.65 B KRW
-37.26 B KRW
Jan 1, 2020
91.52 B KRW
2.38 B KRW
85.58 M KRW
Jan 1, 2021
99.92 B KRW
0.00 KRW
8.18 B KRW
Jan 1, 2022
122.09 B KRW
-2.96 B KRW
-5.57 B KRW
Jan 1, 2023
95.55 B KRW
0.00 KRW
-37.30 B KRW
Jan 1, 2024
129.14 B KRW
0.00 KRW
-31.55 B KRW
Jan 1, 2025
140.19 B KRW
1.70 B KRW
-2.24 B KRW

Cellumed Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 6, 2026, 2:27 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
40.4835.4830.7830.6720.7417.739.8119.0010.8417.9291.5299.92122.0995.55129.14140.19
508.69-12.34-13.25-0.38-32.38-14.49-44.6593.66-42.9565.29410.679.1822.19-21.7335.158.56
64.0418.4721.2921.3730.7525.566.1839.03-3.1111.2516.3214.3711.165.897.354.67
25.926.556.556.556.384.530.617.42-0.342.0214.9414.3613.635.639.496.55
2.22–1.580.86-11.46-8.29-15.60-0.93-12.45-36.652.38–-2.96––1.70
5.48–5.142.81-55.25-46.75-159.00-4.91-114.80-204.502.60–-2.43––1.21
-8.21–0.16–-14.91-11.35-36.85-7.11-9.27-37.260.098.18-5.57-37.30-31.55-2.24
-74.58––––-23.92224.81-80.7130.37302.02-100.239,524.71-168.08569.61-15.42-92.91
7.007.007.007.007.007.007.007.007.007.007.007.007.007.007.007.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cellumed Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cellumed Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cellumed Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cellumed Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cellumed Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cellumed Co stock margins

The Cellumed Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cellumed Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cellumed Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
-3.11 %
-114.80 %
-85.48 %
Jan 1, 2019
11.25 %
-204.49 %
-207.90 %
Jan 1, 2020
16.32 %
2.60 %
0.09 %
Jan 1, 2021
14.37 %
0.00 %
8.19 %
Jan 1, 2022
11.17 %
-2.43 %
-4.56 %
Jan 1, 2023
5.89 %
0.00 %
-39.03 %
Jan 1, 2024
7.35 %
0.00 %
-24.43 %
Jan 1, 2025
4.67 %
1.21 %
-1.59 %

Cellumed Co Stock Revenue, EBIT, Earnings per Share

The Cellumed Co earnings per share therefore indicates how much revenue Cellumed Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2019
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2020
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2021
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2022
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2023
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2024
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2025
0.00 KRW
0.00 KRW
0.00 KRW

Cellumed Co business model & stock analysis

Cellumed Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cellumed Co historical P/E ratio, EBIT multiple, and P/S ratio

Cellumed Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cellumed Co shares outstanding

The number of shares of Cellumed Co was 7 M in 2025. This indicates how many shares Cellumed Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
7.00 M Stocks
Jan 1, 2019
7.00 M Stocks
Jan 1, 2020
7.00 M Stocks
Jan 1, 2021
7.00 M Stocks
Jan 1, 2022
7.00 M Stocks
Jan 1, 2023
7.00 M Stocks
Jan 1, 2024
7.00 M Stocks
Jan 1, 2025
7.00 M Stocks
Price targets and forecasts for Cellumed Co are not yet available.

Cellumed Co shareholder structure

% Name
28.27412%
Inscobee, Inc.
Inscobee, Inc.
5.28424%
FreeTelecom Inc.
FreeTelecom Inc.
0.26730%
Gu (Ja Gap)
Gu (Ja Gap)
0.15808%
Kim (Yong Hui)
Kim (Yong Hui)
0.09453%
Park (Min Ja)
Park (Min Ja)
0.02055%
Yu (In Su)
Yu (In Su)

Cellumed Co Executives and Management Board

9 members · avg. age 49

Management

YY

Yin Su Yoo (59)

Chief Executive Officer, Director · since 2022

–
JJ

Ji Wuk Jung (45)

Managing Director

–
YS

Yeong Taek Song (45)

Assistant Managing Director · since 2010

–
JJ

Ju Wung Jang (44)

Assistant Managing Director

–
JL

Jun Gu Lee (44)

Internal Auditor

–

Board of Directors

JP

Jeong Seop Park (48)

Vice Chairman

–
JK

Jeong Yeol Kim (58)

Director

–
JY

Jae Hun Yoo (49)

Director

–
DS

Dae Seok Seo (49)

Non-Executive Independent Director

–

Frequently asked questions about Cellumed Co

Converted at the current exchange rate, the Cellumed Co share trades at 0.61 EUR (1,009.00 KRW).

No history available for Cellumed Co.

The revenue cannot currently be calculated for Cellumed Co.

The profit cannot currently be calculated for Cellumed Co.

The P/E ratio cannot be calculated for Cellumed Co at the moment.

The P/S cannot be calculated for Cellumed Co currently.

The Eulerpool Quality Score for Cellumed Co is 4/10.

The ISIN of Cellumed Co is KR7049180003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cellumed Co is 049180.KQ. The ticker symbol is used to trade Cellumed Co shares on the stock exchange.

Cellumed Co paid dividends every year for the past 0 years.

Cellumed Co is assigned to the 'Health' sector.

The dividends of Cellumed Co are distributed in KRW.

All fundamentals and in-depth analysis of Cellumed Co

Our stock analysis for Cellumed Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellumed Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cellumed Co Stock
Cellumed Co Revenue→
Cellumed Co Stock
Cellumed Co Net Income→
Cellumed Co Stock
Cellumed Co P/E→
Cellumed Co Stock
Cellumed Co P/S→
Cellumed Co Stock
Cellumed Co EBIT→
Cellumed Co Stock
Cellumed Co Dividend→
Cellumed Co Stock
Cellumed Co Directors Dealings→
Cellumed Co Stock
Cellumed Co Stocks→
Cellumed Co Stock
Cellumed Co Market capitalization→
Cellumed Co Stock
Cellumed Co Debt→
Cellumed Co Stock
Cellumed Co Liabilities→
Cellumed Co Stock
Cellumed Co Equity→
Cellumed Co Stock
Cellumed Co AAQS→
Cellumed Co Stock
Cellumed Co Employees→
Cellumed Co Stock
Cellumed Co ROE→
Cellumed Co Stock
Cellumed Co ROA→
Cellumed Co Stock
Cellumed Co ROCE→
Cellumed Co Stock
Cellumed Co News→
Cellumed Co Stock
Cellumed Co Analyst Price Targets→

Health Stocks

Celon PharmaCelltrion PharmCelularityCelltrionCelyad OncologyCellSource CoCenraCellSeedCenteneCellid CoCentenial Surgical SutureCellectisAll Stocks A–Z →